436 related articles for article (PubMed ID: 9459345)
21. Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.
Mousa SA; Bozarth JM; Lorelli W; Forsythe MS; Thoolen MJ; Slee AM; Reilly TM; Friedman PA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1277-84. PubMed ID: 9732389
[TBL] [Abstract][Full Text] [Related]
22. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
[TBL] [Abstract][Full Text] [Related]
23. Separation of the 100-kDa membrane protein mediating ADP-induced platelet shape change and activation from glycoprotein IIIa.
Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S
Trans Assoc Am Physicians; 1986; 99():39-45. PubMed ID: 3603928
[TBL] [Abstract][Full Text] [Related]
24. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
25. Reduced expression of platelet surface glycoprotein receptor IIb/IIIa at hyperthermic temperatures.
Pasha R; Benavides M; Kottke-Marchant K; Harasaki H
Lab Invest; 1995 Sep; 73(3):403-8. PubMed ID: 7564273
[TBL] [Abstract][Full Text] [Related]
26. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
[TBL] [Abstract][Full Text] [Related]
27. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
Kutok JL; Coller BS
Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915
[TBL] [Abstract][Full Text] [Related]
28. Gender differences in platelet GPIIb-IIIa activation.
Faraday N; Goldschmidt-Clermont PJ; Bray PF
Thromb Haemost; 1997 Apr; 77(4):748-54. PubMed ID: 9134654
[TBL] [Abstract][Full Text] [Related]
29. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
Francischetti IM; Ghazaleh FA; Reis RA; Carlini CR; Guimarães JA
Arch Biochem Biophys; 1998 May; 353(2):239-50. PubMed ID: 9606958
[TBL] [Abstract][Full Text] [Related]
30. Visualization of activation-dependent epitopes on glycoprotein IIb-IIIa complexes of platelets stimulated by thrombin: immunogold staining of ultrathin sections.
Humbert M; Kunicki TJ; Bihour C; Winckler J; Nurden AT; Nurden P
Semin Thromb Hemost; 1996; 22(3):279-88. PubMed ID: 8836014
[TBL] [Abstract][Full Text] [Related]
31. [Construction and characterization of bispecific single-chain antibody fragments SZ-2/SZ-21 against platelet glycoprotein Ib alpha and beta3].
Dai K; An G; Ruan C
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1493-7. PubMed ID: 12509914
[TBL] [Abstract][Full Text] [Related]
32. Specific cross-reaction of IgG anti-phospholipid antibody with platelet glycoprotein IIIa.
Tokita S; Arai M; Yamamoto N; Katagiri Y; Tanoue K; Igarashi K; Umeda M; Inoue K
Thromb Haemost; 1996 Jan; 75(1):168-74. PubMed ID: 8713797
[TBL] [Abstract][Full Text] [Related]
33. Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
Frojmovic MM; Wong T; Searcy GP
Thromb Haemost; 1996 Dec; 76(6):1047-52. PubMed ID: 8972030
[TBL] [Abstract][Full Text] [Related]
34. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
[TBL] [Abstract][Full Text] [Related]
35. A novel regulatory epitope defined by a murine monoclonal antibody to the platelet GPIIb-IIIa complex (alpha IIb beta 3 integrin).
Tokuhira M; Handa M; Kamata T; Oda A; Katayama M; Tomiyama Y; Murata M; Kawai Y; Watanabe K; Ikeda Y
Thromb Haemost; 1996 Dec; 76(6):1038-46. PubMed ID: 8972029
[TBL] [Abstract][Full Text] [Related]
36. GPIIIa(90-102) and GPIIIa(631-653) epitopes as markers of conformational changes occurring during the activation of the glycoprotein IIb/IIIa complex.
Niewiarowska J; Cierniewski CS
Eur J Biochem; 1994 Sep; 224(3):803-9. PubMed ID: 7523118
[TBL] [Abstract][Full Text] [Related]
37. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity.
Jennings LK; White MM; Mandrell TD
Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody, VM64, reacts with a 130 kDa glycoprotein common to platelets and endothelial cells: heterogeneity in antibody binding to human aortic endothelial cells.
Mazurov AV; Vinogradov DV; Kabaeva NV; Antonova GN; Romanov YA; Vlasik TN; Antonov AS; Smirnov VN
Thromb Haemost; 1991 Oct; 66(4):494-9. PubMed ID: 1796401
[TBL] [Abstract][Full Text] [Related]
39. Comparison of tryptic fragments of von Willebrand factor involved in binding to thrombin-activated platelets with fragments involved in ristocetin-induced binding and binding to collagen.
Houdijk WP; Girma JP; van Mourik JA; Sixma JJ; Meyer D
Thromb Haemost; 1986 Dec; 56(3):391-6. PubMed ID: 3551182
[TBL] [Abstract][Full Text] [Related]
40. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets.
Peerschke EI
Thromb Haemost; 1995 May; 73(5):862-7. PubMed ID: 7482417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
